Health2 months ago
FDA Targets Telehealth Firms for Illegal GLP-1 Marketing
The U.S. Food and Drug Administration (FDA) has intensified its enforcement actions against telehealth companies, issuing warning letters to 30 firms for allegedly marketing compounded formulations...
